The Truth is Powerful
THQ: Discount Opening Up In This 6.45% Distribution Yielding Healthcare Fund
THQ had joined the rest of the CEF space in premium territory in 2021.
This was yet another fund that had never traded at a premium previously.
THQ’s distribution yield is sustainable as the NAV yield is reasonable and healthcare remains a defensive sector.
This idea was discussed in more depth with members of my private investing community, CEF/ETF Income Laboratory. Learn More »
malamus-UK/E+ via Getty Images Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on June 26th, 2022. Tekla Healthcare Opportunities Fund (NYSE: THQ ) enjoyed a strong performance in 2021. In particular, the share price performance had eclipsed the performance of the underlying portfolio quite meaningfully. Of course, that means that THQ’s discount had rapidly disappeared. The fund rushed to a premium. This was along with several other funds that had never traded at a premium before.Asset prices across the board were inflated and it was really a tough year to find some great values. I always put money to work every single month, no matter what. However, it really was harder to find things to be enthusiastic about in 2021. This […]